148 related articles for article (PubMed ID: 8613923)
1. The selectivity in vitro of the stereoisomers of the beta-3 adrenoceptor agonist BRL 37344.
Oriowo MA; Chapman H; Kirkham DM; Sennitt MV; Ruffolo RR; Cawthorne MA
J Pharmacol Exp Ther; 1996 Apr; 277(1):22-7. PubMed ID: 8613923
[TBL] [Abstract][Full Text] [Related]
2. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
3. Discrepancies in lipolytic activities induced by beta-adrenoceptor agonists in human and rat adipocytes.
Hollenga C; Haas M; Deinum JT; Zaagsma J
Horm Metab Res; 1990 Jan; 22(1):17-21. PubMed ID: 1968415
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective action of (R*,R*)-(+/-)-methyl-4-[2-[2-hydroxy-2-(3-chlorophenyl)ethylamino] propyl]-phenoxyacetic acid (BRL37344) on beta-adrenoceptors and metabolic chiral inversion.
Ida K; Hashimoto K; Kamiya M; Muto S; Nakamura Y; Kato K; Mizota M
Biochem Pharmacol; 1996 Nov; 52(10):1521-7. PubMed ID: 8937466
[TBL] [Abstract][Full Text] [Related]
5. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
Honda K; Takenaka T; Miyata-Osawa A; Terai M
J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
[TBL] [Abstract][Full Text] [Related]
6. The beta-adrenoceptor selectivity profile of BRL 37344 in the pithed rat.
Oriowo MA; Sennitt MV; Smith SA; Ruffolo RR; Cawthorne MA
J Auton Pharmacol; 1994 Oct; 14(5):337-44. PubMed ID: 7829538
[TBL] [Abstract][Full Text] [Related]
7. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
Mattsson H; Hedberg A; Carlsson E
J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
[TBL] [Abstract][Full Text] [Related]
8. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
[TBL] [Abstract][Full Text] [Related]
9. Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins.
Manara L; Badone D; Baroni M; Boccardi G; Cecchi R; Croci T; Giudice A; Guzzi U; Landi M; Le Fur G
Br J Pharmacol; 1996 Feb; 117(3):435-442. PubMed ID: 8821531
[TBL] [Abstract][Full Text] [Related]
10. Beta 3-adrenoceptors mediating relaxation of the oesophageal tunica muscularis mucosae and distal colon in the rat: comparative pharmacology and their desensitization by BRL 37344.
Kelly J; Houston G
J Auton Pharmacol; 1996 Aug; 16(4):205-11. PubMed ID: 8953375
[TBL] [Abstract][Full Text] [Related]
11. Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines.
Dolan JA; Muenkel HA; Burns MG; Pellegrino SM; Fraser CM; Pietri F; Strosberg AD; Largis EE; Dutia MD; Bloom JD
J Pharmacol Exp Ther; 1994 Jun; 269(3):1000-6. PubMed ID: 7912272
[TBL] [Abstract][Full Text] [Related]
12. Beta3-adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway.
Angelone T; Filice E; Quintieri AM; Imbrogno S; Recchia A; Pulerà E; Mannarino C; Pellegrino D; Cerra MC
Acta Physiol (Oxf); 2008 Jul; 193(3):229-39. PubMed ID: 18208582
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat beta-adrenoceptor subtypes.
Konkar AA; Fraundorfer PF; Fertel RH; Burkman AM; Miller DD; Feller DR
Eur J Pharmacol; 1996 Jun; 305(1-3):63-71. PubMed ID: 8813533
[TBL] [Abstract][Full Text] [Related]
14. The positive chronotropic effect induced by BRL 37344 and CGP 12177, two beta-3 adrenergic agonists, does not involve cardiac beta adrenoceptors but baroreflex mechanisms.
Tavernier G; Galitzky J; Bousquet-Melou A; Montastruc JL; Berlan M
J Pharmacol Exp Ther; 1992 Dec; 263(3):1083-90. PubMed ID: 1361569
[TBL] [Abstract][Full Text] [Related]
15. Identification of potent agonists acting at an endogenous atypical beta3-adrenoceptor state that modulate lipolysis in rodent fat cells.
Hamilton BS; Doods HN
Eur J Pharmacol; 2008 Feb; 580(1-2):55-62. PubMed ID: 18031735
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
[TBL] [Abstract][Full Text] [Related]
17. Progesterone decreases the relaxing effect of the beta3-adrenergic receptor agonist BRL 37344 in the pregnant rat myometrium.
Minorics R; Gáspár R; Gál A; Klukovits A; Falkay G
Reproduction; 2009 Aug; 138(2):383-90. PubMed ID: 19470710
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the beta-adrenoceptor that mediates metabolic responses to the novel agonist BRL28410 in rat soleus muscle.
Challiss RA; Leighton B; Wilson S; Thurlby PL; Arch JR
Biochem Pharmacol; 1988 Mar; 37(5):947-50. PubMed ID: 2830888
[TBL] [Abstract][Full Text] [Related]
19. Adrenergic responses of rat colonic muscularis mucosae.
Percy WH; Keupp SM
J Pharm Pharmacol; 2008 Aug; 60(8):1097-103. PubMed ID: 18644202
[TBL] [Abstract][Full Text] [Related]
20. The preferential beta3-adrenoceptor agonist BRL 37344 increases force via beta1-/beta2-adrenoceptors and induces endothelial nitric oxide synthase via beta3-adrenoceptors in human atrial myocardium.
Pott C; Brixius K; Bundkirchen A; Bölck B; Bloch W; Steinritz D; Mehlhorn U; Schwinger RH
Br J Pharmacol; 2003 Feb; 138(3):521-9. PubMed ID: 12569077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
